the same period of last year and a decrease of 5.28% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales. 2. Cost of sales was 384.25
1,947.37 2,097.62 Selling & Administrative Expense 120.12 127.83 Finance Costs 20.98 24.24 Net Profit 9.12 101.40 Earnings per share (Baht) 0.02 0.25 The company will explain the cause of change as follow: 1
same period of last year and an increase of 24.9% over the last quarter . Such increase was mainly due to the increase in aluminium price and the expansion of sales volume from exporting to overseas
the same period of last year and an increase of 1.71% over the last quarter . Such increase was mainly due to the increase in aluminium price and the expansion of sales volume from exporting to overseas
% from last year and total revenues of 1,603.93 million Baht which also decreased 13.07% from last year. This was mainly due to the lower price of Aluminium (LME). 2. Cost of sales was 1,638.69 million
the same period of last year and a decrease of 30.49% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales caused from the COVID-19 out
approval on behalf of the company, had collusively sought unlawful gain causing damage to BLISS. They decided or proceeded for BLISS?s assets to invest in share warrants of C.I.Group Public Company Limited
expected to have a positive impact on the price of TFG shares that had not been generally disclosed to the public collaboration with Mr. Winai Teawsomboonkij, purchased TFG’s shares and purchased TFG’s
Date Amount Average Price (baht) The methods of Acquisition/Disposition Remark VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED (VIBHA) Major General SURIYA PHALAKORNKUL Spouse / Cohabiting Couple